About Tripartite motif-containing protein 64B
Tripartite motif-containing protein 64B (TRIM64B) is a protein
from Homo sapiens identified by UniProt accession
A6NI03, 449 residues long.
MolForge cross-references it against 0 known binders and
13 disease associations.
Target properties
| Protein name | Tripartite motif-containing protein 64B |
| UniProt accession | A6NI03 |
| Gene | TRIM64B |
| Organism | Homo sapiens |
| Length | 449 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (13)
Diseases linked to this target (Open Targets).
- smoking status measurement · score 0.12
- homocysteine measurement · score 0.04
- lean body mass · score 0.03
- fat body mass · score 0.03
- adolescent idiopathic scoliosis · score 0.03
- body mass index · score 0.03
- body fat percentage · score 0.03
- sunburn · score 0.03
- pulse pressure measurement · score 0.03
- hair colour measurement · score 0.02
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-A6NI03-F1 | alphafold | PREDICTED | 85.07 | — |
Amino-acid sequence (449 residues)
MDSDDLQVFQ NELICCICVN YFIDPVTIDC GHSFCRPCLC LCSEEGRAPM RCPSCRKTSE KPNFNTNLVL KKLSSLARQT RPQNINSSDN ICVLHEETKE LFCEADKRLL CGPCSESPEH MAHSHSPIGW AAEECREKLI KEMDYLWEIN QETRNNLNQE TSTFHSLKDY VSVRKRIITI QYQKMPIFLD EEEQRHLQAL EREAEELFQQ LQDSQVRMTQ HLERMKDMYR ELWETCHMPD VVLLQDVRNV SARTDLAQMQ KPQPVNPELT SWCITGVLDM LNNFRVDSAL STEMIPCYIS LSEDVRYVIF GDDHLSAPTD PQGVDSFAVW GAQAFTSGKH YWEVDVTLSS NWILGVCRDS RTADANFVID SDERFFLISS KRSNHYSLST NSPPLIQYVQ RPLGRVGVFL DYDNGSVSFF DVSKGSLIYG FPPSSFSSPL RPFFCFGCT
Explore Tripartite motif-containing protein 64B with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets